Researchers want to pick up the pace on early testing and treatment for COVID-19

In addition to early testing, the researchers call for the development of small-scale, rapid-response outpatient studies that use viral-shedding metrics and symptoms to assess the risk of disease progression. Such therapeutics could include antiviral drugs such as remdesivir, favipiravir and selinexor, as well as a growing list of antibody formulations. GeekWire